Accuray (ARAY) Stock: Buy, Sell, or Hold?
ARAY - Accuray Incorporated
$0.28
0.01 (5.16%)
▲
5d:
+30.64%
30d:
+8.08%
90d:
+3.69%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Get Alerted When ARAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ARAY shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ARAY shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: ARAY is currently trading at $0.28, which is considered extended relative to its 30-day fair value range of $0.23 to $0.28. From a valuation perspective, the stock is trading at a discount (Forward PE: -0.9) compared to its historical average (39.3). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, ARAY is in a downtrend. Immediate support is located at $0.22, while resistance sits at $0.38. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: ARAY scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $0.35 (+24.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARAY is in a downtrend. Immediate support is located at $0.22, while resistance sits at $0.38. The stock is showing strong short-term momentum, up 5.2% recently.
Market Sentiment: ARAY scores 8/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $0.35 (+24.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.23 -
$0.28
Company Quality Score
34/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
28.6%
Protect Your Profits
Holding ARAY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (8/100)
- BULLISH: Strong upward momentum (+5.2%)
- BULLISH: Trading 24.6% below Wall St target ($0.35)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.23 -
$0.28
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.22
Resistance Level
$0.38
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.94
Wall Street Target
$0.35
(+24.6%)
Revenue Growth (YoY)
-20.9%
Earnings Growth (YoY)
-96.2%
Profit Margin
-12.2%
PE vs Historical
-0.9 vs 39.3
CHEAP
Share & Embed Analysis
Last updated: October 03, 2026 3:55 PM ET
Data refreshes hourly during market hours. Next update: 4:55 PM
Data refreshes hourly during market hours. Next update: 4:55 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARAY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$61 | 62 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 47 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 51 HOLD |
|
GKOS
Glaukos Corp |
STRONG BUY
15 analysts |
$199 | 72 BUY |
Advanced ARAY Option Strategies
Professional options setups generated by AI based on today's ARAY price and gamma walls.
